On the 30 September 2026 Flerie AB's Net Asset Value (NAV) was SEK 3,113 million and NAV per share was SEK 35.91. Return on NAV per share in the month was -6.8%.

Allocation of NAV
Share of portfolio company
Fair value (MSEK)
Part of NAV per share (SEK)
Share of NAV
Product Development
Lipum
100%
348
4.01
11.2%
Prokarium
50%
296
3.41
9.5%
Atrogi
47%
215
2.48
6.9%
KAHR Medical
34%
214
2.47
6.9%
Microbiotica
10%
191
2.20
6.1%
Bonsai Biotherapeutics
100%
158
1.82
5.1%
AnaCardio
9%
105
1.22
3.4%
Mendus
22%
89
1.03
2.9%
Xintela
60%
88
1.02
2.8%
Xspray Pharma
17%
85
0.98
2.7%
Geneos Therapeutics
12%
71
0.82
2.3%
EpiEndo Pharmaceuticals
9%
56
0.65
1.8%
Vitara Biomedical
9%
51
0.58
1.6%
Egetis Therapeutics
1%
43
0.50
1.4%
Buzzard Pharmaceuticals
15%
33
0.38
1.1%
Amarna Therapeutics
58%
11
0.13
0.4%
Strike Pharma
18%
11
0.12
0.3%
Empros Pharma
79%
0
0.00
0.0%
Total
2,065
23.82
66.3%





Commercial Growth
Symcel
30%
211
2.43
6.8%
NorthX Biologics
61%
202
2.33
6.5%
Chromafora
29%
149
1.72
4.8%
Nanologica
50%
50
0.58
1.6%
Frontier Biosolutions
2%
27
0.31
0.9%
Bohus Biotech
45%
22
0.26
0.7%
Total
661
7.63
21.2%





Assets and liabilities related to Portfolio companies
131
1.51
4.2%
Other assets and liabilities
256
2.95
8.2%
Net Asset Value
3,113
35.91
100.0% 


For more information:
Ted Fjällman, CEO
Email: ir@flerie.com

Flerie in brief
Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. We invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access. Flerie’s active ownership model, broad network and resources support and accelerate the development of the portfolio projects, creating value for shareholders. Flerie AB’s ordinary share is listed on Nasdaq Stockholm with the ticker FLERIE. For further information please visit www.flerie.com

Läs mer på MFN

Ämnen i artikeln


Flerie

Senast

14,30

1 dag %

−3,38%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån